QuidelOrtho Appoints Micah Young as CFO Amid Strategic Leadership Transition

QuidelOrtho Corporation (QDEL) strengthens its leadership team with the appointment of Micah Young as the new Chief Financial Officer, effective July 6, 2026. Young takes over from Joseph M. Busky, who is retiring but will remain in an advisory capacity to ensure a seamless transition. This strategic decision comes as QuidelOrtho, a global leader in diagnostic solutions, emphasizes the need for robust financial leadership during a transformative period for the company.

Micah Young's Extensive Background

Micah Young brings a wealth of experience in the medical technology sector, highlighted by his tenure as Executive Vice President and CFO at Masimo Corporation. Under his leadership, Masimo underwent a significant strategic transformation and achieved substantial operational improvements since 2017. Young's comprehensive background also includes senior finance roles at NuVasive, Inc., and vital contributions to finance and accounting at Zimmer Holdings, Inc., demonstrating a strong foundation in financial management. This blend of expertise positions him well to steer QuidelOrtho's financial strategies toward enhancing cash flow and profitability.

Brian J. Blaser, President and CEO of QuidelOrtho, expresses his confidence in Young's capabilities to fulfill the company's strategic priorities. Notably, improving profitability, boosting cash generation, and driving long-term shareholder value are at the forefront of QuidelOrtho's agenda. The leadership transition occurs during a time when the company seeks to navigate challenges, particularly following a reported net loss of $1.13 billion, and aims to better its position in the marketplace.

A Focused Vision for the Future

In addition to Young’s appointment, QuidelOrtho continues to focus on its vision for growth and operational excellence. The transition in financial leadership reflects a commitment to strategic execution and positions the company favorably as it prepares to tackle competitive challenges head-on. With Young at the financial helm, QuidelOrtho is poised to advance its mission of delivering innovative diagnostic solutions to the global healthcare community.

As the company reinforces its leadership and strategic direction, stakeholders remain optimistic. QuidelOrtho's strong institutional ownership, at 99.0%, indicates a deep-rooted belief in its growth prospects, despite the challenges it faces in the diagnostic landscape. This renewed leadership signals a hopeful path forward as the company works on its financial and operational improvements.